Baiama

Aflibercept is a medication used for intravitreal administration to manage certain eye conditions. This biologic therapy is designed to target specific proteins involved in ocular health.

Aflibercept is primarily used for intravitreal administration to address conditions related to abnormal blood vessel growth in the eye. It is often prescribed for conditions like wet age-related macular degeneration, diabetic macular edema, and macular edema following retinal vein occlusion. Patients may wonder, 'What is Aflibercept used for?' This medication works by inhibiting vascular endothelial growth factor (VEGF), which can help reduce swelling and prevent further damage to the retina.

Common effects of Aflibercept may include temporary vision disturbances, eye redness, or discomfort at the injection site. Some patients might experience increased floaters or mild irritation. These effects are generally short-lived and should be discussed with a healthcare provider if they persist or worsen.

Aflibercept should be handled with care, ensuring proper sterile techniques during administration. Patients should inform their healthcare provider about any existing eye infections or allergies. Regular eye examinations are recommended to monitor for any adverse reactions or changes in vision.

Aflibercept may interact with other medications, particularly those that affect the immune system or blood clotting. Patients should avoid alcohol while using this medication, as it can exacerbate side effects. Always consult a healthcare provider before starting or stopping any medication.